Josh Blacher is Chief Financial Officer of BullFrog AI and is responsible for financial and accounting operations, capital markets strategy, and corporate development. With more than two decades of financial leadership experience in the life sciences, Josh’s prior experience includes Chief Financial and Business Officer for InMed Pharmaceuticals, Therapix Biosciences, and Galmed Pharmaceuticals. Earlier in his career, Josh served in senior capacities at Teva Pharmaceuticals, Deutsche Asset Management and Morgan Stanley. He earned his Bachelor of Arts in Economics from Yeshiva University and an MBA in Finance from Columbia Business School.